Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Sphenopalatine Ganglion Block in Cluster Headache
NCT02019017Phase 2Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in Cluster Headache (CH), sponsored by Norwegian University of Science and Technology. Started Oct 2013; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Cluster Headache (CH)
Beyond the preview
Go deeper on NCT02019017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02019017.